NetworkNewsBreaks

WednesdayOct 15, 2025 9:40 am

NetworkNewsBreaks – Alliance Creative Group, Inc. (OTC: ACGX) Expands Digital Portfolio with Acquisition of Three Industry Websites

Alliance Creative Group (OTC: ACGX) announced the acquisition of three established online platforms serving the hospitality, education, and legal sectors, marking a strategic expansion of its AI-driven digital media ecosystem. The transaction, completed through a mix of cash and restricted stock, includes a consulting agreement to align long-term interests between ACGX and the sellers. “These new acquisitions are an important part of our foundation,” said Paul Sorkin, CEO of Alliance Creative Group. “We’re acquiring established digital properties in industries with room for modernization and growth.” The acquired sites will be upgraded with enhanced technology, AI integration, and improved monetization strategies…

Continue Reading

WednesdayOct 15, 2025 9:30 am

NetworkNewsBreaks – United States Antimony Corporation (NYSE American: UAMY) (NYSE Texas: UAMY) Raises $25 Million Through Securities Purchase Agreement with Leading Mutual Fund

US Antimony, a producer and processor of antimony, zeolite, and other critical minerals, announced it has entered into a securities purchase agreement with a leading long-only mutual fund for approximately $25 million in gross proceeds. The funds will support inventory expansion, additional leasehold acquisitions in Alaska and Montana, potential capacity increases at the Madero Smelter, strategic acquisitions, and general working capital. Chairman and CEO Gary C. Evans noted the Company has raised $69.25 million in three tranches over the past 45 days from two major institutions at progressively higher share prices, strengthening its institutional shareholder base. Titan Partners Group, a…

Continue Reading

WednesdayOct 15, 2025 9:20 am

NetworkNewsBreaks – FAVO Capital (OTC: FAVO) Appoints Gary F. Baumann as Independent Director

FAVO Capital (OTC: FAVO), a diversified financial company with operations in financial services and real estate, announced the appointment of Gary F. Baumann, Esq., as an independent director to its board. A founding partner of Baumann, Gant, Keeley & Biondi, P.A., Baumann brings over 25 years of experience in construction and commercial litigation, having tried more than 70 civil jury cases and advised developers and institutions on compliance and risk management. “Gary’s appointment reflects our ongoing commitment to building a board with the independence, experience, and perspective needed to guide FAVO’s next phase of growth,” said Shaun Quin, President of FAVO…

Continue Reading

WednesdayOct 15, 2025 9:10 am

NetworkNewsBreaks – Lahontan Gold Corp. (TSXV: LG) (OTCQB: LGCXF) Submits Notice of Operations to BLM for Drilling at West Santa Fe Project

This article has been disseminated on behalf of Lahontan Gold and may include a paid advertisement. Lahontan Gold (TSXV: LG) (OTCQB: LGCXF) announced it has submitted a Notice of Operations to the U.S. Bureau of Land Management for its planned exploration drilling program at the West Santa Fe Project, located 13 kilometers southwest of the Company’s flagship Santa Fe Mine Project. The Notice covers multiple drill sites, access roads, and drilling sumps as Lahontan prepares to twin historic holes, drill down-dip, and test mineralization along strike. Historical work totaling 171 drill holes over 13,000 meters outlined shallow, oxidized gold and silver…

Continue Reading

WednesdayOct 15, 2025 9:00 am

NetworkNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Signs LOI to Acquire NYIAX, Expanding Blockchain and Exchange Capabilities Across Global Markets

Datavault AI (NASDAQ: DVLT), a pioneer in AI-driven data valuation, monetization, and acoustic technologies, announced it has signed a letter of intent to acquire NYIAX Inc., a technology and services company with operations in the U.S., Europe, and Dubai. The proposed acquisition, subject to Nasdaq approval and execution of a definitive agreement, would integrate NYIAX’s blockchain-powered exchange, patent portfolio, marketing-as-a-service agency, and advertising unit into Datavault AI’s expanding ecosystem. The deal builds on an existing licensing partnership for Datavault AI’s ADIO(R) ultrasonic technology and will enhance its patented Information Data Exchange(R) (IDE) platform by adding transparent, automated trading capabilities. Datavault…

Continue Reading

TuesdayOct 14, 2025 3:37 pm

NetworkNewsBreaks – DealFlow Events to Host 2025 PIPEs Conference at Hard Rock Hotel in Hollywood, Florida 

DealFlow Events will host The PIPEs Conference on Nov. 12–13, 2025, at the Hard Rock Hotel and Casino in Hollywood, Florida, bringing together public issuers, investors, and industry leaders for two days of expert panels, private meetings, and high-level networking. Building on the success of its 2024 relaunch, the event will feature sessions on regulatory developments, market trends, and transaction strategies, with insights from top firms including Loeb & Loeb, Sheppard Mullin, Maxim Group, and Roth Capital Partners. Attendees will engage in presentations and roundtables covering topics such as PIPEs in DeSPAC deals, crypto-related investments, valuation practices, and the evolving…

Continue Reading

TuesdayOct 14, 2025 3:17 pm

NetworkNewsBreaks – RADR(R) Platform Powers Lantern Pharma Inc.’s (NASDAQ: LTRN) Push Into Rare Pediatric Brain Cancer Treatment

Lantern Pharma (NASDAQ: LTRN) is developing a number of clinical trials, using its proprietary drug candidates and computational biology and machine learning platform, to target conditions with unmet medical needs. The company was featured in a recent article that discussed its preparation for the launch of a trial targeting a rare pediatric disease, planned for Q1 2026. This comes “in the wake of its optimistic meeting with the U.S. Food and Drug Administration (‘FDA’) to receive critical guidance on the company’s trial design and the FDA’s regulatory pathway… Lantern Pharma is developing its clinical trial with the hope of demonstrating the…

Continue Reading

TuesdayOct 14, 2025 2:57 pm

NetworkNewsBreaks – New Patent Strengthens Wearable Devices Ltd.’s (NASDAQ: WLDS) IP in Neural Interfaces for XR, Industry, Assistive Tech

Wearable Devices (NASDAQ: WLDS, WLDSW) was granted a new U.S. patent that protects groundbreaking neural interface technology that measures weight, torque, and force directly from wrist-based sensors with applications spanning XR, industrial automation, and assistive technology. This was featured in a recent article that reads, “The patent encompasses voice-controlled interfaces and innovations in brain-computer interfaces, strengthening the company’s intellectual property position in the rapidly expanding $260 billion AI wearables market… WLDS’s newly granted patent titled ‘Gesture and Voice-Controlled Interface Device’ represents significant advancement in neural interface intellectual property. Unlike typical gesture patents focused on movement recognition, this protection covers neural measurement…

Continue Reading

TuesdayOct 14, 2025 2:54 pm

NetworkNewsBreaks – Sustain Southern California to Host 16th Annual Energy Event Focused on Clean Energy and Decarbonization

Sustain SoCal will host its 16th Annual Energy Event, themed “Energy in Perspective,” on Oct. 16, 2025, at The Cove at UCI Beall Applied Innovation in Irvine, California. The conference will bring together more than 200 leaders, investors, and policymakers to explore solutions in clean energy and decarbonization across industrial, commercial, and government sectors. Key topics include renewables, hydrogen, nuclear, natural gas and renewable natural gas, near-zero and waste-to-energy technologies, transmission infrastructure, energy storage, and policy impacts as Sustain SoCal continues its mission to advance cleantech-driven sustainability throughout the region. To view the full press release, visit https://nnw.fm/BSpSg About Sustain…

Continue Reading

TuesdayOct 14, 2025 2:20 pm

NetworkNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Updates U.S. Medical Advisory Board to Advance Phase 3 Development of HyBryte for CTCL 

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on treatments for rare diseases, announced updates to its U.S. Medical Advisory Board for cutaneous T-cell lymphoma (CTCL) to support the ongoing Phase 3 development of HyBryte(TM) (synthetic hypericin). The board, comprised of leading dermatologic and oncologic experts, will provide strategic guidance as Soligenix advances regulatory and commercialization activities for its photodynamic therapy. President and CEO Christopher J. Schaber, PhD, said the addition of new key opinion leaders reinforces the program’s clinical depth and the company’s commitment to bringing HyBryte to CTCL patients worldwide. To view the full press release, visit https://nnw.fm/an9rs…

Continue Reading